Atos, which has given up its place to Eurofins, has at the same time increased by 2%. The analysis laboratory is the victim of a combination of negative factors and in particular the consequences of It is a victim of a combination of negative factors, in particular the consequences of its inclusion in the index on 17 September, as Vincent Lequertier, head of asset allocation at WeSave, a subsidiary of Amundi, explains. There's nothing alarming about this beautiful...
Eurofins Scientific share price has lost 13% since it was first listed on the CAC 40
